People shop at a Manhattan grocery store on August 13, 2026, in New York City. Spencer Platt | Getty Images The largest ever outbreak of cyclosporiasis in the U.S. has ended, the Centers for Disease Control and Prevention said Friday. The foodborne illness sickened 12,833 people in 21 states in recent months in the largest…
American patients would ultimately bear the cost of President Donald Trump‘s threatened tariffs on generic drugs, the CEO of Swiss pharmaceutical company Sandoz told CNBC, warning that manufacturers could be forced to raise prices or stop supplying some medicines. “Patients pay the tariff,” Sandoz CEO Richard Saynor said in an interview with CNBC during its…
AstraZeneca on Tuesday released full results from two successful late-stage trials on its experimental drug for chronic obstructive pulmonary disease, boosting hopes that it could generate multibillion-dollar sales for the company. The biologic medicine, tozorakimab, is under priority review by the Food and Drug Administration, with U.S. approval expected in the first quarter of 2027….
FILE PHOTO: The logo of Swiss drugmaker Novartis is seen at the company’s new cell and gene therapy factory in Stein, Switzerland, November 28, 2019. Arnd Wiegmann | Reuters Novartis shares tanked 10% on Tuesday after the pharmaceutical giant said its del-desiran drug for muscle-wasting disorder failed in a late-stage trial. The company’s stock was…
Blood sample for a lipoprotein(a) test. Md Babul Hosen | Istock | Getty Images Novartis‘ failure in a closely watched cardiovascular trial has raised questions about one of the pharmaceutical industry’s biggest drug races and rival treatments from U.S. heavyweights Amgen and Eli Lilly. The pelacarsen drug, developed jointly with Ionis Pharmaceuticals, reduced a particularly…
Momo Productions | Digitalvision | Getty Images Employers are increasingly turning to the 401(k) playbook to boost their workers’ uptake of health savings accounts. HSAs are tax-advantaged accounts that carry powerful financial benefits relative to other types of savings accounts. They carry a three-pronged tax break: Money that savers contribute to HSAs doesn’t count toward…
Stanley Druckenmiller at CNBC’s Delivering Alpha on Sept. 28, 2022. Scott Mlyn | CNBC A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Investment firms of ultra-wealthy families are helping fuel the…
CNBC’s Jim Cramer said Monday that August was a comeback month for stocks that had been battered by some of Wall Street’s most powerful bearish narratives. His comments came on the final trading day of August. Several of the S&P 500‘s biggest winners in August spent months under pressure from concerns ranging from artificial intelligence…
U.S. President Donald Trump delivers remarks on his administration’s healthcare policies, in the Oval Office at the White House in Washington, D.C., U.S., Aug. 31, 2026. Evelyn Hockstein | Reuters President Donald Trump on Monday said he struck new drug pricing deals with nine drugmakers to voluntarily sell their medications for less, building on his…
The cyclospora outbreak that has sickened thousands of people across the U.S. has brought fresh scrutiny of the integral role Taylor Farms and other massive suppliers play in the country’s food supply. The company, which the Food and Drug Administration has linked to the parasite’s spread, is one of the world’s largest producers of fresh-cut…
